Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127750001 | 12775000 | 1 | I | 20160915 | 20160923 | 20160923 | EXP | GB-MLMSERVICE-20160912-0407541-1 | GB-STRIDES ARCOLAB LIMITED-2016SP013964 | STRIDES | 0.00 | Y | 0.00000 | 20160923 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127750001 | 12775000 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | UNK | 90055 | |||||||||||
| 127750001 | 12775000 | 2 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 2.5 G, UNK | 90055 | 2.5 | G | |||||||||
| 127750001 | 12775000 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 1.5 MG/KG, UNK | U | U | 0 | 1.5 | MG/KG | |||||||
| 127750001 | 12775000 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | UNK (40-60 MG/DAY) | U | U | 0 | |||||||||
| 127750001 | 12775000 | 5 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 20 MG/DAY | U | U | 0 | 20 | MG | |||||||
| 127750001 | 12775000 | 6 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 40 MG, UNK | U | U | 0 | 40 | MG | |||||||
| 127750001 | 12775000 | 7 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 20 MG/DAY | U | U | 0 | 20 | MG | |||||||
| 127750001 | 12775000 | 8 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 40 MG, DAILY | U | U | 0 | 40 | MG | |||||||
| 127750001 | 12775000 | 9 | SS | INFLIXIMAB | INFLIXIMAB | 1 | 5 MG/KG, (AT WEEKS 0,2,6, AND 8 WEEKLY) | 0 | 5 | MG/KG | INFUSION | ||||||||
| 127750001 | 12775000 | 10 | SS | INFLIXIMAB | INFLIXIMAB | 1 | 5 MG/KG, (6-WEEKLY) | 0 | 5 | MG/KG | INFUSION | ||||||||
| 127750001 | 12775000 | 11 | SS | INFLIXIMAB | INFLIXIMAB | 1 | 5 MG/KG, (8-WEEKLY) | 0 | 5 | MG/KG | INFUSION | ||||||||
| 127750001 | 12775000 | 12 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 1 G, TID | 0 | 1 | G | ||||||||
| 127750001 | 12775000 | 13 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | UNK | 0 | |||||||||||
| 127750001 | 12775000 | 14 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 480 MG, THRICE A WEEK | 0 | 480 | MG | |||||||||
| 127750001 | 12775000 | 15 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | 0 | |||||||||||
| 127750001 | 12775000 | 16 | C | TRIAMCINOLONE | TRIAMCINOLONE | 1 | Ophthalmic | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127750001 | 12775000 | 1 | Immunosuppression |
| 127750001 | 12775000 | 3 | Uveitis |
| 127750001 | 12775000 | 9 | Uveitis |
| 127750001 | 12775000 | 12 | Uveitis |
| 127750001 | 12775000 | 14 | Lymphopenia |
| 127750001 | 12775000 | 16 | Uveitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127750001 | 12775000 | OT |
| 127750001 | 12775000 | LT |
| 127750001 | 12775000 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127750001 | 12775000 | Dyspnoea | |
| 127750001 | 12775000 | Intestinal obstruction | |
| 127750001 | 12775000 | Multiple organ dysfunction syndrome | |
| 127750001 | 12775000 | Pneumonia | |
| 127750001 | 12775000 | Pyrexia | |
| 127750001 | 12775000 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |